PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.
http://www.peervoice.com
Gesamtlänge aller Episoden: 10 days 18 hours 42 minutes
Evolving the Treatment Paradigm in Metastatic HER2-Positive Breast Cancer: The Ongoing Story of Emerging Treatments
Evolving the Treatment Paradigm in Metastatic HER2-Positive Breast Cancer: The Ongoing Story of Emerging Treatments
GnRH Antagonist vs LHRH Agonist: To Desensitize or To Inhibit, That Is the Question!
GnRH Antagonist vs LHRH Agonist: To Desensitize or To Inhibit, That Is the Question!
Practical Strategies in Optimising Subcutaneous Immunoglobulin Replacement Therapy
Practical Strategies in Optimising Subcutaneous Immunoglobulin Replacement Therapy
Stroke Prevention, Type 2 Diabetes, and GLP-1 Receptor Agonists: What Neurologists Need to Know
Stroke Prevention, Type 2 Diabetes, and GLP-1 Receptor Agonists: What Neurologists Need to Know
Beyond HPIs for Advanced Basal Cell Carcinoma: Exploring the Clinical Implications of New Evidence
Beyond HPIs for Advanced Basal Cell Carcinoma: Exploring the Clinical Implications of New Evidence
Modern Management of Chronic Kidney Disease: A Look to the Future
Modern Management of Chronic Kidney Disease: A Look to the Future
Cardiovascular Risk and Prostate Cancer: Clinical Perspectives on ADT
Cardiovascular Risk and Prostate Cancer: Clinical Perspectives on ADT
Proactive IBD Care: Identifying Patients at Risk of Disease Progression
Proactive IBD Care: Identifying Patients at Risk of Disease Progression
The Impact of Earlier Diagnosis and Timelier Treatment of Primary Hyperoxaluria Type 1
The Impact of Earlier Diagnosis and Timelier Treatment of Primary Hyperoxaluria Type 1